$1.15
0.00% today
Nasdaq, Dec 02, 08:47 pm CET
ISIN
US4277461020
Symbol
HRTX

Heron Therapeutics Inc Stock price

$1.15
-0.03 2.54% 1M
-0.78 40.41% 6M
-0.38 24.84% YTD
-0.07 5.74% 1Y
-1.53 57.09% 3Y
-16.35 93.43% 5Y
-29.73 96.28% 10Y
-123.65 99.08% 20Y
Nasdaq, Closing price Mon, Dec 01 2025
-0.01 0.86%
ISIN
US4277461020
Symbol
HRTX
Industry

Key metrics

Basic
Market capitalization
$210.9m
Enterprise Value
$187.6m
Net debt
positive
Cash
$55.5m
Shares outstanding
183.3m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
1.4 | 1.3
EV/Sales
1.2 | 1.2
EV/FCF
negative
P/B
14.2
Financial Health
Equity Ratio
-14.4%
Return on Equity
40.4%
ROCE
1.0%
ROIC
-
Debt/Equity
2.2
Financials (TTM | estimate)
Revenue
$155.1m | $159.6m
EBITDA
$4.0m | -
EBIT
$1.6m | $4.4m
Net Income
$-13.6m | $-5.6m
Free Cash Flow
$-31.1m
Growth (TTM | estimate)
Revenue
12.6% | 10.6%
EBITDA
117.0% | -
EBIT
106.2% | 138.0%
Net Income
51.4% | 58.7%
Free Cash Flow
-224.0%
Margin (TTM | estimate)
Gross
73.9%
EBITDA
2.6% | -
EBIT
1.0%
Net
-8.8% | -3.5%
Free Cash Flow
-20.1%
More
EPS
$-0.1
FCF per Share
$-0.2
Short interest
24.7%
Employees
122
Rev per Employee
$1.2m
Show more

Is Heron Therapeutics Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,078 stocks worldwide.

Heron Therapeutics Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

10 Analysts have issued a Heron Therapeutics Inc forecast:

9x Buy
90%
1x Hold
10%

Analyst Opinions

10 Analysts have issued a Heron Therapeutics Inc forecast:

Buy
90%
Hold
10%

Financial data from Heron Therapeutics Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
155 155
13% 13%
100%
- Direct Costs 40 40
6% 6%
26%
115 115
15% 15%
74%
- Selling and Administrative Expenses 101 101
0% 0%
65%
- Research and Development Expense 12 12
52% 52%
8%
3.96 3.96
117% 117%
3%
- Depreciation and Amortization 2.36 2.36
10% 10%
2%
EBIT (Operating Income) EBIT 1.60 1.60
106% 106%
1%
Net Profit -14 -14
51% 51%
-9%

In millions USD.

Don't miss a Thing! We will send you all news about Heron Therapeutics Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Heron Therapeutics Inc Stock News

Neutral
Seeking Alpha
28 days ago
Heron Therapeutics, Inc. ( HRTX ) Q3 2025 Earnings Call November 4, 2025 8:30 AM EST Company Participants Melissa Jarel - Executive Director of Legal Craig Collard - CEO & Director Mark Hensley - Executive VP & COO Ira Duarte - Executive VP & CFO Kevin Warner - Senior Vice President of Medical Affairs Strategy & Engagement William Forbes - Executive VP & Chief Development Officer Conference Cal...
Neutral
GlobeNewsWire
28 days ago
Generated Q3 2025 Net Revenue of $38.2 million and year-to-date revenue of $114.3 million; reaffirmed 2025 Net Revenue Guidance of $153 million - $163 million and adjusted EBITDA of $9.0 - $13.0 million ZYNRELEF ® Net Revenue grew 49% in Q3 2025, as compared to Q3 2024, continuing momentum with the launch of the Vial Access Needle (VAN) and enhanced incentive program with key distributors APONV...
Neutral
GlobeNewsWire
about one month ago
CARY, N.C., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Heron Therapeutics, Inc. (Nasdaq: HRTX) (“Heron” or the “Company”), a commercial-stage biotechnology company, today announced the appointment of Thomas Cusack to its Board of Directors. Mr. Cusack has extensive experience in matters related to corporate finance, investment management, and corporate governance. Mr. Cusack was appointed to the Board p...
More Heron Therapeutics Inc News

Company Profile

Heron Therapeutics, Inc. is a biotechnology company, which engages in the development of pharmaceutical products for patients suffering from cancer. Its products portfolio include SUSTOL, Cinvanti, HTX-011, and HTX-034. The company was founded in February 1983 and is headquartered in Redwood City, CA.

Head office United States
CEO Craig Collard
Employees 122
Founded 1983
Website www.herontx.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today